Rosehill Resources Inc. and Rosehill Operating Company, LLC Emerge from Chapter 11
HOUSTON, Sept. 08, 2020 (GLOBE NEWSWIRE) — Rosehill Resources Inc. (“RRI”) and Rosehill Operating Company, LLC (“Rosehill Operating” and together […]
BeyondSpring Receives Breakthrough Therapy Designations from Both U.S. FDA and China NMPA for Plinabulin in Chemotherapy-Induced Neutropenia Indication
– FDA Breakthrough Designation for CIN Indication: Plinabulin for Concurrent Administration with Myelosuppressive Chemotherapeutic Regimens in Patients with Non-Myeloid Malignancies […]
LGI Homes Introduces New Floor Plan Lineup With New Community in Tucson
TUCSON, Ariz., Sept. 08, 2020 (GLOBE NEWSWIRE) — LGI Homes, Inc. (Nasdaq:LGIH) announced a lineup of five new floor plans at […]
BrainsWay to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
CRESSKILL, N.J. and JERUSALEM, Israel, Sept. 08, 2020 (GLOBE NEWSWIRE) — BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the […]
ALX Oncology Announces Participation at Upcoming Investor Conferences
BURLINGAME, Calif., Sept. 08, 2020 (GLOBE NEWSWIRE) — ALX Oncology Holdings Inc., (“ALX Oncology”) (Nasdaq: ALXO) a clinical-stage immuno-oncology company […]
Protara Therapeutics Provides Comparability and U.S. Regulatory Updates for TARA-002 Supporting Advancement in Oncology and Rare Disease Indications
– Company Demonstrates Initial Comparability Between TARA-002 and OK-432, Advancing to Final GMP Comparability Runs –– Reaches Alignment with FDA […]
Codexis to Present at Two Virtual Investment Conferences in September
REDWOOD CITY, Calif., Sept. 08, 2020 (GLOBE NEWSWIRE) — Codexis, Inc. (Nasdaq: CDXS), a leading protein engineering company, announces that […]
FibroGen Appoints Percy Carter, MBA, PhD, as Chief Scientific Officer
SAN FRANCISCO, Sept. 08, 2020 (GLOBE NEWSWIRE) — FibroGen, Inc. (NASDAQ: FGEN) announced the appointment of Percy Carter, MBA, PhD, […]
Aravive to Participate in Upcoming Virtual Investor Conferences in September
HOUSTON, Sept. 08, 2020 (GLOBE NEWSWIRE) — Aravive, Inc. (Nasdaq: ARAV), a clinical-stage oncology company developing transformative therapeutics, today announced […]
Evelo Biosciences to Participate in Upcoming Investor Conferences in September
CAMBRIDGE, Mass., Sept. 08, 2020 (GLOBE NEWSWIRE) — Evelo Biosciences, Inc. (Nasdaq:EVLO), a clinical stage biotechnology company developing a new […]
